HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David J Moliterno Selected Research

vorapaxar

12/2018Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.
1/2018Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
1/2018Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial.
3/2017Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial.
8/2016Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.
5/2016Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.
5/2016Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy.
1/2016Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
12/2015Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery.
5/2015Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David J Moliterno Research Topics

Disease

65Hemorrhage
09/2022 - 01/2002
63Myocardial Infarction
01/2020 - 01/2002
61Acute Coronary Syndrome
01/2019 - 01/2002
38Thrombosis (Thrombus)
01/2020 - 02/2002
21Stroke (Strokes)
03/2022 - 12/2002
14Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 07/2006
12ST Elevation Myocardial Infarction
01/2018 - 02/2002
10Ischemia
03/2017 - 12/2002
8Atrial Fibrillation
01/2021 - 07/2009
8Death (Near-Death Experience)
01/2020 - 11/2013
6Thrombocytopenia (Thrombopenia)
11/2009 - 05/2004
5Infarction (Infarctions)
06/2013 - 02/2002
4Diabetes Mellitus
09/2022 - 12/2003
4Chronic Renal Insufficiency
09/2022 - 01/2009
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 10/2011
4Anemia
01/2019 - 10/2004
4Heart Failure
10/2013 - 06/2012
3Peripheral Vascular Diseases (Peripheral Vascular Disease)
11/2018 - 09/2003
3Shock
10/2013 - 05/2008
3Myocardial Ischemia (Ischemic Heart Diseases)
09/2012 - 10/2004
3Inflammation (Inflammations)
07/2012 - 02/2002
3Unstable Angina
12/2008 - 07/2002
2Thromboembolism
01/2021 - 07/2009
2Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2018 - 01/2012
2Non-ST Elevated Myocardial Infarction
01/2018 - 02/2012
2Coronary Thrombosis
05/2016 - 02/2008
2Peripheral Arterial Disease
10/2014 - 10/2006
2Necrosis
11/2013 - 07/2012
2Hypertension (High Blood Pressure)
12/2003 - 12/2003
1Hemorrhagic Stroke
12/2018
1Embolic Stroke
11/2016
1Albuminuria
08/2016
1Acute Kidney Injury (Acute Renal Failure)
08/2016
1Heart Diseases (Heart Disease)
11/2013
1Tachycardia (Tachyarrhythmias)
08/2011

Drug/Important Bio-Agent (IBA)

23Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2022 - 04/2002
22vorapaxarIBA
12/2018 - 03/2009
17Thrombin Receptors (Thrombin Receptor)IBA
12/2018 - 01/2012
132'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
03/2022 - 11/2013
12Glycoproteins (Glycoprotein)IBA
01/2018 - 01/2002
12Clopidogrel (Plavix)FDA Link
05/2016 - 10/2003
12Abciximab (ReoPro)FDA Link
06/2011 - 01/2002
11Tirofiban (Aggrastat)FDA Link
06/2011 - 05/2002
11Heparin (Liquaemin)FDA LinkGeneric
11/2009 - 08/2002
10Platelet Membrane Glycoprotein IIbIBA
05/2015 - 10/2002
9AnticoagulantsIBA
01/2021 - 07/2003
7ThrombinFDA Link
01/2015 - 02/2002
6TicagrelorIBA
09/2022 - 01/2014
6omega-Chloroacetophenone (Mace)IBA
10/2019 - 11/2013
6thienopyridineIBA
03/2017 - 02/2007
6Platelet Membrane GlycoproteinsIBA
02/2008 - 01/2002
6paragonIBA
02/2008 - 07/2002
5CreatinineIBA
01/2018 - 12/2003
5Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
12/2015 - 04/2002
5Pharmaceutical PreparationsIBA
09/2014 - 01/2002
4Peptide Hydrolases (Proteases)FDA Link
12/2018 - 03/2014
4MetalsIBA
09/2014 - 09/2006
4Biomarkers (Surrogate Marker)IBA
05/2014 - 07/2012
3Vitamin KFDA Link
01/2021 - 08/2012
3PAR-1 ReceptorIBA
12/2015 - 07/2014
3Warfarin (Coumadin)FDA LinkGeneric
08/2012 - 10/2011
3AntithrombinsIBA
02/2012 - 02/2002
3Enoxaparin (Lovenox)FDA LinkGeneric
04/2005 - 01/2003
2TroponinIBA
01/2014 - 11/2013
2pro-brain natriuretic peptide (1-76)IBA
10/2013 - 07/2012
2Proteinase-Activated ReceptorsIBA
06/2013 - 09/2012
2Digoxin (Digitek)FDA LinkGeneric
05/2013 - 08/2011
2Fibrinogen (Factor I)FDA Link
09/2012 - 01/2005
2Interleukin-6 (Interleukin 6)IBA
07/2012 - 12/2003
2pexelizumabIBA
11/2009 - 05/2008
2N(2)-(3-trifluoromethylphenyl)guanineIBA
11/2009 - 05/2008
2Eptifibatide (Integrilin)FDA Link
02/2008 - 07/2002
2Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2006 - 04/2002
2sibrafibanIBA
08/2003 - 06/2002
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
12/2002 - 10/2002
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2002 - 02/2002
1Hemoglobins (Hemoglobin)IBA
01/2019
1protease-activated receptor 4IBA
01/2018
1SuspensionsIBA
10/2017
1apixabanIBA
01/2016
1trans-crotonin (CTN)IBA
11/2013
1ThromboxanesIBA
09/2012
1Adenosine Diphosphate (ADP)IBA
09/2012
1Dicumarol (Dicoumarol)FDA Link
08/2012
1Brain Natriuretic Peptide (Natrecor)FDA Link
07/2012
1CytokinesIBA
07/2012
1Protein CIBA
12/2010

Therapy/Procedure

54Therapeutics
03/2022 - 01/2002
41Stents
01/2021 - 01/2002
40Percutaneous Coronary Intervention
09/2022 - 01/2002
13Drug-Eluting Stents
03/2022 - 09/2006
9Patient Readmission
03/2017 - 11/2009
5Coronary Artery Bypass (Coronary Artery Bypass Surgery)
05/2015 - 12/2002
4Thrombolytic Therapy
08/2006 - 02/2002
3Secondary Prevention
12/2018 - 06/2002
3Blood Transfusion (Blood Transfusions)
07/2013 - 05/2004
2Length of Stay
01/2018 - 01/2009
2Transcatheter Aortic Valve Replacement
09/2012 - 06/2012
2Combination Drug Therapy (Combination Chemotherapy)
04/2002 - 02/2002
1Polypharmacy
12/2012